Supported by: Wilhelm Sander-Stiftung, DFG-Graduiertenkolleg 639, and BMBF Kompetenznetz “Paediatrische Onkologie und Haematologie.”
Characterization of primary wilms tumor cultures as an in vitro model†
Article first published online: 27 OCT 2011
Copyright © 2011 Wiley Periodicals, Inc.
Genes, Chromosomes and Cancer
Volume 51, Issue 1, pages 92–104, January 2012
How to Cite
Wegert, J., Bausenwein, S., Roth, S., Graf, N., Geissinger, E. and Gessler, M. (2012), Characterization of primary wilms tumor cultures as an in vitro model. Genes Chromosom. Cancer, 51: 92–104. doi: 10.1002/gcc.20936
- Issue published online: 4 NOV 2011
- Article first published online: 27 OCT 2011
- Manuscript Accepted: 7 SEP 2011
- Manuscript Received: 12 MAY 2011
- 2003. Derivation and characterization of a Wilms' tumour cell line, WiT 49. Int J Cancer 107: 365–374. , , .
- 2006. Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS Genet 2: e169. , , , , , , , , , , .
- 1994. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7: 91–97. , , , , , , , , , .
- 1989. Loss of chromosome 11p alleles in cultured cells derived from Wilms' tumours. Br J Cancer 60: 25–29. , , , , , , .
- 2007. High-throughput telomere length quantification by FISH and its application to human population studies. Proc Natl Acad Sci USA 104: 5300–5305. , , , .
- 2002. Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47. .
- 2008. Molecular cytogenetic anomalies and phenotype alterations in a newly established cell line from Wilms tumor with diffuse anaplasia. Cancer Genet Cytogenet 184: 22–30. , , , , , , , .
- 1985. The in vitro growth and characterization of the skeletal muscle component of Wilms' tumor. Am J Pathol 121: 298–310. , , , , , .
- 1987. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor. Am J Pathol 129: 353–363. , , , , , .
- 1993. The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney. Am J Pathol 142: 375–380. , , , , .
- 1990. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774–778. , , , , , .
- 1993. Morphology and growth characteristics of epithelial cells from classic Wilms' tumors. Am J Pathol 142: 893–905. , , , , .
- 1994. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line. Am J Pathol 144: 1023–1034. , , , .
- 2007. The pediatric preclinical testing program: Description of models and early testing results. Pediatr Blood Cancer 49: 928–940. , , , , , , , , , , , , , , , , , , , , , , , , , .
- 2011. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest 121: 174–183. , , , , , , , , , .
- 2009. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: A report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res 15: 1770–1778. , , , , , , , , , , .
- 1998. Wilms tumor genetics. Am J Med Genet 79: 260–267. .
- 1999. Mutational activation of the β-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59: 3880–3882. , , , , , , , .
- 1998. Novel WT1 mutation, 11p LOH, and t(7;12) (p22;q22) chromosomal translocation identified in a Wilms' tumor case. Genes Chromosomes Cancer 21: 347–350. , , , , , .
- 2007. CITED1 expression in Wilms' tumor and embryonic kidney. Neoplasia 9: 589–600. , , , , , , , , , .
- 2007. Wilms tumor suppressor WTX negatively regulates WNT/β-catenin signaling. Science 316: 1043–1046. , , , , , , , , , , , .
- 2001. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: A histologic and immunophenotypic comparison. Am J Surg Pathol 25: 1290–1296. , , .
- 1980. Growth patterns, ultrastructure, and chromosomal constitution of normal kidney and nephroblastoma cells in short-term culture. J Pediatr Surg 15: 297–302. , , , .
- 1988. Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution. Am J Pathol 133: 596–608. , , , .
- 1974. Behaviour of Wilms tumour and normal metanephros in organ culture. Eur J Cancer 10: 461–466. , , .
- 2010. Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm. Hum Mol Genet 19: 1651–1668. , , , , , , , .
- 1999. Tissue culture of human renal epithelial cells using a defined serum-free growth formulation. Exp Nephrol 7: 344–352. , , , , , .
- 2008. SK-NEP-1 and Rh1 are Ewing family tumor lines. Pediatr Blood Cancer 50: 703–706. , , , , , .
- 2002. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99: 12606–12611. , , , , , , , , , , , .
- 1993. Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice. Int J Cancer 54: 868–874. , , , , , .
- 2002. Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res 273: 21–33. , , , , , .
- 2009. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact. Genes Chromosomes Cancer 48: 1102–1111. , , , , , .
- 2010. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor. Clin Cancer Res 16: 2036–2045. , , , , , , , , , , , , , .
- 2007. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis. Genes Chromosomes Cancer 46: 163–170. , , , , , .
- 2008. New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer 47: 386–395. , , , , , , .
- 2005a. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene 24: 5246–5251. , , , , , .
- 2005b. Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development. Cancer Lett 220: 115–120. , , , .
- 2006. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 118: 1954–1962. , , , , , , , , .